Artemis Therapeutics, Inc. - FORM 10-K - EX-23.1 - March 30, 2011

Attached files

file filename
10-K - Artemis Therapeutics, Inc.zk1109673.htm
EX-31.2 - Artemis Therapeutics, Inc.exhibit_31-2.htm
EX-31.1 - Artemis Therapeutics, Inc.exhibit_31-1.htm
EX-10.6 - Artemis Therapeutics, Inc.exhibit_10-6.htm
EX-32.1 - Artemis Therapeutics, Inc.exhibit_32-1.htm
 

                                                                    EXHIBIT 23.1

             INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT

We consent to the incorporation by reference in Registration Statement No.
333-130168 on Form S-8 of our report dated March 29, 2011, relating the
financial statements of InkSure Technologies Inc. , appearing in this Annual
Report on Form 10-K of InkSure Technologies Inc. for the year ended December 31,
2010.

Brightman Almagor Zohar & Co.
Certified Public Accountants,
A member firm of  Deloitte Touche Tohmatsu

Tel Aviv, Israel
March 29, 2011

Stock widget

Investing forum

Artemis Therapeutics, Inc. Reports